We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

As previously reported, Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down from $340, as ...

Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...

Amid all the volatility, some companies are proving resilient by performing much better than the market. Some of these look ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Amgen operates in the global pharmaceutical industry (with a focus on its biotech segment). By 2023, the entire pharmaceutical market was estimated at $1.3 trillion. According to analysts at ...

In the latest trading session, Amgen (AMGN) closed at $277.29, marking a -1.89% move from the previous day. This change lagged the S&P 500's 0.13% gain on the day. At the same time, the Dow lost 1 ...

Shares of UnitedHealth and Amgen are posting losses Thursday morning, propelling the Dow Jones Industrial Average selloff.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...